Teva Pharmaceutical Industries Limited Share Price TEL AVIV STOCK EXCHANGE
Stocks
TEVA
IL0006290147
Pharmaceuticals
OTC Markets Traded|
Delayed
TEL AVIV STOCK EXCHANGE
08:11:39 09/09/2026 BST
|
5-day change | 1st Jan Change | ||
| 11,030.00 ILa | +1.01% |
|
+0.27% | +9.42% |
| 09-04 | S&P Global Ratings Upgrades Teva Pharmaceutical to 'BBB-' | MT |
| 09-03 | Vaxcyte Names New Medical and Legal Chiefs Ahead of Key Phase 3 Data | MT |
| Market Cap | 42.84B 0 36.83B 34.65B 31.62B 59.01B 4,061B 59.32B 411B 159B 2,076B 161B 157B 6,605B | P/E 2026 * |
49.3x | P/E 2027 * | 20.2x |
|---|---|---|---|---|---|
| Enterprise Value | 54.74B 0 47.06B 44.28B 40.41B 75.41B 5,189B 75.8B 525B 203B 2,652B 206B 201B 8,441B | EV / Sales 2026 * |
3.3x | EV / Sales 2027 * | 2.98x |
| Free-Float |
88.59% | Yield 2026 * |
-
| Yield 2027 * | - |
| Markets | Quality | ||
|---|---|---|---|
TEL AVIV STOCK EXCHANGE
| TEVA | Delayed | |
OTC Markets
| TEVJF | Delayed |
Last Transcript : Teva Pharmaceutical Industries Limited
| 1 day | +1.10% | ||
| 1 week | +0.27% | ||
| Current month | +3.08% | ||
| 1 month | +3.66% | ||
| 3 months | +13.67% | ||
| 6 months | +17.14% | ||
| Current year | +9.42% |
| 1 week | 10,680 |  | 11,450 |
| 1 month | 10,450 | | 11,530 |
| Current year | 8,860 | | 11,530 |
| 1 year | 6,082 | | 11,530 |
| 3 years | 3,250 | | 11,530 |
| 5 years | 2,383 | | 11,530 |
| 10 years | 2,175 | | 19,900 |
| Manager | Title | Age | Since |
|---|---|---|---|
Richard Francis
CEO | Chief Executive Officer | 57 | 31/12/2022 |
Eli Kalif
DFI | Director of Finance/CFO | 53 | 21/12/2019 |
Matthew Shields
COO | Chief Operating Officer | 52 | 02/06/2024 |
| Director | Title | Age | Since |
|---|---|---|---|
Amir Elstein
BRD | Director/Board Member | 69 | 31/12/2008 |
Sol Barer
CHM | Chairman | 78 | 05/02/2017 |
Rosemary Crane
BRD | Director/Board Member | 65 | 31/08/2015 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +1.01% | +0.27% | - | - | 42.84B | |
| -2.21% | -3.11% | +52.16% | +91.64% | 1,002B | |
| -2.22% | -0.76% | +51.08% | +67.61% | 649B | |
| -2.99% | -4.31% | +18.59% | +66.94% | 440B | |
| -0.68% | 0.00% | +29.48% | +37.53% | 346B | |
| -0.72% | -15.31% | +8.98% | +25.94% | 263B | |
| +0.08% | -0.73% | -0.73% | +13.20% | 250B | |
| -10.08% | -10.26% | +40.32% | +51.55% | 213B | |
| -1.34% | -4.19% | -14.67% | -57.74% | 201B | |
| -2.88% | -2.19% | +26.54% | +92.95% | 182B | |
| Average | -1.85% | -2.06% | +23.53% | +43.29% | 393.74B | |
| Weighted average by Cap. | -1.35% | -2.39% | +32.84% | +57.69% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 16.59B 0 14.26B 13.42B 12.25B 22.86B 1,573B 22.97B 159B 61.52B 804B 62.3B 60.94B 2,558B | 17.3B 0 14.88B 14B 12.77B 23.84B 1,641B 23.96B 166B 64.17B 839B 64.98B 63.56B 2,668B |
| Net income | 1.44B 0 1.24B 1.17B 1.06B 1.99B 137B 2B 13.81B 5.34B 69.83B 5.41B 5.29B 222B | 2.69B 0 2.31B 2.17B 1.98B 3.7B 255B 3.72B 25.77B 9.97B 130B 10.1B 9.87B 415B |
| Net Debt | 11.9B 0 10.23B 9.63B 8.79B 16.4B 1,128B 16.48B 114B 44.13B 577B 44.7B 43.72B 1,835B | 8.65B 0 7.44B 7B 6.39B 11.92B 820B 11.98B 82.92B 32.08B 419B 32.49B 31.78B 1,334B |
| Date | Price | Change | Volume |
|---|---|---|---|
| 09/09/26 | ILA 11,030.00 | +1.01% | 90,984 |
| 08/09/26 | ILA 10,920.00 | +0.09% | 1,086,826 |
| 07/09/26 | ILA 10,910.00 | -0.46% | 499,288 |
| 04/09/26 | ILA 10,960.00 | -0.36% | 473,654 |
| 03/09/26 | ILA 11,000.00 | -0.09% | 983,311 |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- TEVA Stock
- TEVA Stock
Select your edition
All financial news and data tailored to specific country editions
